Mechanistic model of hormonal contraception
Authors: A Armean Wright, Ghassan N Fayad, James F Selgrade, Mette S Olufsen
Journal: PLOS Computational Biology
Accepted: 2020-04-03T00:00:00Z


Contraceptive drugs intended for family planning are used by the majority of married or in-union women in almost all regions of the world. The two most prevalent types of hormones associated with contraception are synthetic estrogens and progestins. Hormonal based contraceptives contain a dose of a synthetic progesterone (progestin) or a combination of a progestin and a synthetic estrogen. In this study we use mathematical modeling to understand better how these contraceptive paradigms prevent ovulation, special focus is on understanding how changes in dose impact hormonal cycling. To explain this phenomenon, we added two autocrine mechanisms essential to achieve contraception within our previous menstrual cycle models. This new model predicts mean daily blood concentrations of key hormones during a contraceptive state achieved by administering progestins, synthetic estrogens, or a combined treatment. Model outputs are compared with data from two clinical trials: one for a progestin only treatment and one for a combined hormonal treatment. Results show that contraception can be achieved with synthetic estrogen, with progestin, and by combining the two hormones. An advantage of the combined treatment is that a contraceptive state can be obtained at a lower dose of each hormone. The model studied here is qualitative in nature, but can be coupled with a pharmacokinetic/pharamacodynamic (PKPD) model providing the ability to fit exogenous inputs to specific bioavailability and affinity. A model of this type may allow insight into a specific drug’s effects, which has potential to be useful in the pre-clinical trial stage identifying the lowest dose required to achieve contraception.
Author summary: This study presents a mathematical model for hormonal control of the menstrual cycle of adult women with special emphasis on the effects of oral contraceptive drugs. Our model predicts daily blood levels of ovarian and pituitary hormones in close agreement with data found in the biological literature for normally cycling women. In particular, we study reproductive hormones which are produced by the pituitary gland in the brain and which promote the development of ovarian follicles and the production of ovarian hormones. In turn, the ovarian hormones affect the synthesis and release of the pituitary hormones. We use this model to test the effects of different oral contraceptive treatments. We show that the administration of synthetic progesterone or of synthetic estrogen have a contraceptive effect by preventing ovulation. We illustrate that low doses of each drug given together are most effective at achieving contraception. In addition, model simulations indicate how quickly a combined contraceptive treatment produces a non-ovulatory menstrual cycle and how fast the cycle returns to normal after the treatment ends. If we couple our model with a model for absorption and metabolism of oral contraceptive drugs, the resulting model may help discover minimal effective doses of these drugs and may lead to patient-specific dosing strategies.